Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 67, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2022.102292
Keywords
-
Categories
Ask authors/readers for more resources
Psoriasis and psoriatic arthritis are chronic inflammatory diseases that have a negative impact on quality of life. Understanding the disease mechanisms is crucial for selecting treatment options.
Psoriasis and psoriatic arthritis are chronic inflammatory diseases affecting the skin and joints, respectively. Psoriasis and psoriatic arthritis are associated with a high comorbidity burden as well as negative impact on quality of life. Impact on health-related quality of life is optimized when both skin and joint manifestations are effectively treated. The identification of key cytokines involved in disease pathogenesis has led to the development of several therapeutic options for psoriatic disease. When selecting a therapy, it is important to consider disease severity, psoriasis disease subtypes or domains of psoriatic arthritis, comorbidities, patient preference for treatment, among other factors. This review summarizes current biologic and small molecule treatment options as well as emerging therapies for moderate-to-severe adult plaque psoriasis and psoriatic arthritis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available